HELLP syndrome
ICD-10 O14.2 is a billable code used to indicate a diagnosis of hellp syndrome.
HELLP syndrome is a severe form of pre-eclampsia characterized by hemolysis, elevated liver enzymes, and low platelet count. It typically occurs in the third trimester of pregnancy or shortly after delivery. The condition is associated with significant maternal and fetal morbidity and mortality. Patients may present with symptoms such as abdominal pain, nausea, vomiting, and headache. Diagnosis is based on laboratory findings, including elevated liver enzymes (AST and ALT), low platelet count (<100,000/µL), and evidence of hemolysis (elevated bilirubin and low haptoglobin). Management involves immediate stabilization of the mother, often requiring hospitalization, and may include the administration of magnesium sulfate to prevent seizures, antihypertensive medications to control blood pressure, and timely delivery of the fetus, which is the definitive treatment. Close monitoring of both maternal and fetal well-being is essential during this critical period.
Detailed documentation of maternal symptoms, laboratory findings, and treatment protocols is essential for accurate coding.
Patients presenting with severe hypertension, abdominal pain, or abnormal lab results in the context of pregnancy.
Ensure that all clinical findings are documented clearly to support the diagnosis of HELLP syndrome.
Comprehensive documentation of high-risk factors, fetal monitoring, and maternal health status is critical.
Management of pregnancies complicated by HELLP syndrome, including monitoring for fetal distress.
Consideration of the timing of delivery and its impact on maternal and fetal outcomes.
Used for comprehensive obstetric care including management of HELLP syndrome.
Complete documentation of prenatal visits, labor, delivery, and postpartum care.
Obstetricians should ensure all aspects of care are documented to support billing.
Key symptoms include severe headache, abdominal pain, nausea, vomiting, and visual disturbances. Laboratory findings typically show elevated liver enzymes, low platelet count, and signs of hemolysis.
